UK Research and Innovation is reviewing the intellectual-property conditions attached to public funding as policymakers consider how to retain more economic value from university spinouts that receive taxpayer-backed research support.
Chief executive Sir Ian Chapman told the UK Private Capital annual summit that UKRI’s current intellectual-property terms are unusually liberal compared with other G7 research funders and confirmed that the organisation is examining them again.
“At the moment, the UKRI terms and conditions on IP [intellectual property] are the most liberal of any research investor in any of the G7 countries,” Chapman said, adding: “We are having a look at that again.”
The comments do not amount to a completed policy or an announced restriction on companies moving overseas. They indicate that the public research funder is considering whether its conditions should change as government pays closer attention to where the commercial value generated by publicly supported science ultimately sits.
The issue reflects a longstanding tension in the UK research economy. British universities produce substantial scientific research and a growing pipeline of spinout companies, but successful businesses can later move headquarters, manufacturing or listings overseas as they seek larger pools of capital.
International growth is not inherently evidence of policy failure. Companies working in life sciences, semiconductors, quantum technology or advanced materials often need global investors and commercial partners to reach viable scale. The question is whether the UK retains sufficient employment, research capability, tax revenue and intellectual property after supporting the underlying science.
Grant conditions are one possible lever, but they carry trade-offs. Founders and investors generally favour flexibility because businesses need to license technology, bring in new shareholders and enter overseas markets as they grow.
Restrictive conditions attached to intellectual property can make a company harder to finance if investors are uncertain whether patents can be transferred, licensed or exploited internationally. Any changes would therefore have to protect public value without making UK-backed technologies less attractive to private capital.
The debate also reaches into university technology-transfer policy. Spinouts often begin with intellectual property licensed from a university, meaning founders already have to negotiate equity, royalties and control before external investors arrive.
Government has spent several years trying to standardise those arrangements and reduce friction around spinout formation. Tightening public-funding conditions in a way that adds a second layer of uncertainty could work against that objective unless the rules are clear and proportionate.
A parallel policy approach is to make remaining in the UK commercially attractive rather than relying primarily on restrictions. British Business Bank funding programmes, institutional investment reforms and attempts to deepen domestic growth capital are intended to give scaling businesses more financing options at home.
Those measures matter because relocation decisions are often driven by access to capital, customers and specialist staff rather than corporate preference alone. A company that needs several hundred million pounds to build manufacturing capacity will consider jurisdictions where that funding and infrastructure are available.
Chapman’s comments therefore open a potentially significant policy discussion without resolving it. UKRI has not published a replacement intellectual-property framework, and the precise conditions being considered are not yet established.
Any final change will need to balance two objectives that can pull in opposite directions: maximising the domestic return from publicly funded research while keeping the UK attractive to founders and investors building globally competitive companies. The detail of UKRI’s eventual proposal will determine whether those aims can be reconciled.
You must be logged in to post a comment.